CORD-19:2008f024274c53b0de1276f4047a6a641813fd98 / 453863-454017 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/CORD-19/sourceid/2008f024274c53b0de1276f4047a6a641813fd98","sourcedb":"CORD-19","sourceid":"2008f024274c53b0de1276f4047a6a641813fd98","text":"After model risk adjustment, patients using nebulized ICS had a 53% risk reduction for hospitalization/ED recurrence vs those not using nebulized ICS (HR:","tracks":[{"project":"CORD-19-Sentences","denotations":[{"id":"T33584","span":{"begin":0,"end":154},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T33584","pred":"source","obj":"CORD-19-Sentences"}]},{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T45","span":{"begin":0,"end":154},"obj":"Sentence"}],"attributes":[{"subj":"T45","pred":"source","obj":"CORD-19_Custom_license_subset"}]},{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T4518","span":{"begin":54,"end":57},"obj":"Disease"},{"id":"T4519","span":{"begin":146,"end":149},"obj":"Disease"}],"attributes":[{"id":"A4518","pred":"mondo_id","subj":"T4518","obj":"http://purl.obolibrary.org/obo/MONDO_0016575"},{"id":"A4519","pred":"mondo_id","subj":"T4519","obj":"http://purl.obolibrary.org/obo/MONDO_0016575"},{"subj":"T4518","pred":"source","obj":"CORD-19-PD-MONDO"},{"subj":"T4519","pred":"source","obj":"CORD-19-PD-MONDO"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"CORD-19-Sentences","color":"#ec939d","default":true},{"id":"CORD-19_Custom_license_subset","color":"#93b7ec"},{"id":"CORD-19-PD-MONDO","color":"#d1ec93"}]}]}}